Innovation New Jersey
  • Home
  • Our Coalition
    • Contact Us
  • News
  • Resources
    • State Supports
    • Federal Supports
    • Higher Ed Supports
  • Join Us

Innovation News

Everything Innovation. Everything New Jersey.
Follow us and stay connected.

Building a First-Class Innovation Economy in New Jersey

2/17/2018

0 Comments

 
Trenton, NJ - The New Jersey Biotechnology Task Force heard testimony from representatives in both academia and industry to help define the challenges and opportunities in building a first-class innovation economy in New Jersey. The Task Force was established pursuant to P.L. 2016, Joint Resolution No. 5, to develop policy recommendations to retain and attract new biotechnology companies to New Jersey and encourage greater collaboration between industry and academia.
​Task Force Chair Debbie Hart, who serves as president and chief executive officer of BioNJ, said, “We heard compelling and important testimony from biotechnology company executives and academic institution leaders that will provide a framework for the recommendations of the task force. New Jersey is at a tipping point where policy and innovation are intersecting in a thoughtful and deliberate way. Given the interest by government in making a difference and activity in our ecosystem such as the establishment of the Princeton University and Celgene incubators, I am more bullish on the future opportunity for the industry in New Jersey than ever before.”

On Thursday, the Task Force heard testimony from representatives of Princeton University; Rutgers, The State University of NJ; Rowan University; NJIT; and, Stevens Institute of Technology.  Remarks were largely focused on existing efforts related to industry collaboration and technology transfer, as well as gaps and challenges.  On Friday, testimony was provided by representatives of New Jersey’s biotechnology industry, including Visikol, Inc. and Quixgen, Inc., both current tenants of the New Jersey Economic Development Authority’s (EDA’s) Commercialization Center for Innovative Technologies (CCIT), the State’s leading life sciences incubator; CCIT graduate and Cranbury-based Amicus Therapeutics, which today is a global biotechnology company employing hundreds around the world; Jersey City-based SCYNEXIS, Inc.; Hackensack Meridian Health; and, commercial real estate company Jones Lang LaSalle.  Industry testimony focused on government and private resources, as well as strategic partnerships, that have been leveraged to support continued growth in New Jersey.

“New Jersey has a rich tradition of national leadership in biotechnology and it is critical to the economic well-being of our state that we leverage our history and existing ecosystem as we plan for 2018 and beyond,” Assemblyman Andrew Zwicker (Legislative District 16), Vice Chair of the Biotechnology Task Force, said. “Bringing together key stakeholders from academia and the private sector to testify in front of the Task Force provides my colleagues in the Legislature and me with the information we need to ensure that New Jersey not only nurtures companies that currently reside in our state, but is home to the next generation of biotechnology companies.”

When available, full transcripts of testimony will be provided courtesy of the Office of Legislative Services.  The Task Force is accepting written testimony from representatives of the academic and business community through February 12, 2018.

The Task Force is comprised of six legislative members, including Assemblyman Zwicker, Senator Linda Greenstein (Legislative District 14), Senator Robert Gordon (Legislative District 38), Senator Robert Singer (Legislative District 30),  Assemblyman Christopher DePhillips (Legislative District 40), and Assemblyman Gary Schaer (Legislative District 36); two public members appointed by the Governor, including Debbie Hart, and Daniel O’Connor, Chief Executive Officer of OncoSec Medical Incorporated; and, Timothy Lizura, President and Chief Executive Officer of the EDA, serving in an ex-officio capacity.  The EDA serves as staff to the Task Force.

“The Task Force has been charged with identifying ways to help strengthen the biotechnology industry and propel the growth of New Jersey’s innovation economy,” Lizura said.  “The testimony we have heard to date has been informative and compelling, and we look forward to advancing a robust list of policy recommendations to ensure New Jersey’s legacy of innovation continues.”

The Task Force expects to submit a report of recommendations to the Governor and Legislature in March 2018.
0 Comments



Leave a Reply.

    Do not miss a single innovative moment and sign up for our newsletter!
    Weekly updates


    Categories

    All
    3D Printing
    Academia
    Acquisitions
    Aerospace
    Agriculture
    AIDS
    Algae
    Alumni
    Animals
    Architecture
    Astrophysics
    Autism
    Awards
    Big Data
    Bioethics
    Biofuel
    Biomedical
    BioNJ
    Bioterrorism
    Bit Coins
    Brain Health
    Business
    Camden
    Cancer
    CCollege
    Cellular
    Centenary
    Chemistry
    ChooseNJ
    Climate Change
    Clinical Trials
    Cloud Tech
    Collaboration
    Computing
    Congress
    Coriell
    Council On Innovation
    Crowdfunding
    Cybersecurity
    DARPA
    Defense
    Degree
    Dementia
    Dental Health
    DOC
    DOD
    DOE
    Drew
    Drones
    Drug Creation
    Einstein's Alley
    Electricity
    Energy
    Engineering
    Entrepreneurship
    Environmental
    FAA
    Fairleigh Dickinson
    FDA
    Federal Budget
    Federal Government
    Federal Labs
    Federal Program
    Finance
    Food Science
    Fort Monmouth
    Fuel Cells
    Funding
    Genome
    Geography
    Geology
    Global Competition
    Google
    Governor Christie
    Grant
    Hackensack
    HackensackUMC
    Healthcare
    Health Care
    HHS
    HINJ
    Hospitals
    Immigration
    Incubator
    Infrastructure
    International
    Internet
    Investor
    IoT
    IP
    IT
    Jobs
    Johnson & Johnson
    K-12
    Kean
    Kessler
    Legislation
    Logistics
    Manufacturing
    Medical Devices
    Med School
    Mental Health
    Mentor
    Microorganisms
    Molecular Biology
    Montclair
    NAS
    Neuroscience
    Newark
    New Jersey
    NIFA
    NIH
    NIST
    NJBDA
    NJBIA
    NJ Chemistry Council
    NJCU
    NJDOLWD
    NJEDA
    NJEDge
    NJHF
    NJII
    NJIT
    NJMEP
    NJPAC
    NJPRO
    NJTC
    Nonprofit
    NSF
    OpEd
    Open Data
    OSHE
    OSTP
    Parasite
    Patents
    Paterson
    Patients
    Perth Amboy
    Pharma
    POTUS
    PPPL
    Princeton
    Prosthetics
    Ranking
    Rare Disease
    R&D Council
    Report
    Resiliency
    Rider
    Robotics
    Rowan
    Rutgers
    SBA
    Seton Hall
    Siemens
    Smart Car
    Smart Cities
    Software
    Solar
    Space
    SSTI
    Startup
    State Government
    STEM
    Stevens
    Stockton
    Subatomic
    Supports
    Sustainability
    Taxes
    TCNJ
    Teachers
    Telecom
    Therapy
    Thermodynamics
    Transportation
    Undergraduate
    USEDA
    Verizon
    Video Game
    Virtual Reality
    Water
    WHO
    William Paterson
    Women In STEM
    Workforce Development

Powered by Create your own unique website with customizable templates.